Irregular delay of adjuvant chemotherapy correlated with poor outcome in stage II-III colorectal cancer

BMC Cancer

Table 2 Differences of clinicopathological parameters among TD, DpC-short and -long subgroups

	TD			DpC
	Short	Long	P	Short	Long	P
Age (y)			0.37			0.84
< 60	58	23		45	36
≥ 60	29	7		19	17
Sex			0.27			0.17
Male	60	17		46	31
Female	27	13		18	22
Tumor location			1.00			1.00
Right	25	8		18	15
Left	62	22		46	38
Tumor morphology			0.26			0.23
Ulcerated type	44	13		36	21
Protruded type	12	9		9	12
Mixed type	5	1		4	2
Unknown	26	7		15	18
Histological differentiation			0.04^*			0.37
Well + moderate	64	28		48	44
Poor	23	2		16	9
Mucinous element			0.08			0.80
With	10	8		9	9
Without	77	22		55	44
Combined T stages			0.11			0.04^*
T₁ + T₂ + T₃	73	21		56	38
T₄	14	9		8	15
Combined N stages			0.81			0.84
N₀	23	7		17	13
N₁₊N₂	64	23		47	40
TNM stages			0.81			0.84
II	23	7		17	13
III	64	23		47	40
Tumor deposits			0.78			0.63
With	14	6		12	8
Without	73	24		52	45
Risk factors			0.14			1.00
None	40	19		32	27
≥ 1	47	11		32	26

ISSN: 1471-2407